Neoplasms: all 9,617 studies
Page 46 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.
- Obstruction of Malignancy: Percutaneous Renal vs Endoscopic StentWithdrawnNCT05640115Early Phase 1
- A Study of RD14-01 in Patients With Advanced Solid TumorsStatus unknownNCT05638828Early Phase 1
- Study of CHS-114 in Participants With Advanced Solid TumorsActive, not recruitingNCT05635643Phase 1
- A JZP341 Study in Adult Participants With Advanced or Metastatic Solid TumorsTerminatedNCT05631327Phase 1
- Artificial Intelligence for Determination of Gastroscopy Surveillance IntervalsStatus unknownNCT05631015
- A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour MalignanciesTerminatedNCT05629689Phase 1
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)Active, not recruitingNCT05629234Phase 3
- QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient ManagementStatus unknownNCT05626764
- A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid TumorsCompletedNCT05625412Phase 1
- The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)Status unknownNCT05624827Not applicable
- A Study to Characterize Access to Specialty Care Received by American Indians/Alaska NativesCompletedNCT05624788
- Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid TumorsStatus unknownNCT05623891Early Phase 1
- Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal NeoplasmsActive, not recruitingNCT05623787Not applicable
- Phase I Study of the BBP-398 in Patients With Advance Solid TumorsTerminatedNCT05621525Phase 1
- A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid TumorsActive, not recruitingNCT05621486Phase 1
- Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsActive, not recruitingNCT05620862Phase 1
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerActive, not recruitingNCT05620134Phase 1/2
- Cancer Prevention for Young Rural AdultsActive, not recruitingNCT05618158Not applicable
- Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 TabletsActive, not recruitingNCT05618028Phase 1
- An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive RisksActive, not recruitingNCT05617391
- Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical TrialActive, not recruitingNCT05611632Not applicable
- A Case Series on Incidentally Detected Gallbladder MalignancyCompletedNCT05606029
- A Post-Authorization, Long-term Study of Ozanimod Real-world SafetyActive, not recruitingNCT05605782
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm StudyActive, not recruitingNCT05602935Phase 2
- A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin CancerStatus unknownNCT05602337
- Mindfulness-based Virtual Reality InterventionStatus unknownNCT05602051Not applicable
- A Phase 1 Study of ADA-011 for Subjects With Advanced Solid TumorsTerminatedNCT05601219Phase 1
- A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast CancerWithdrawnNCT05600582Phase 1
- Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)WithdrawnNCT05600556Not applicable
- Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsActive, not recruitingNCT05599984Phase 1
- Pancreatic and Periampullary Tumors in Greenland InuitCompletedNCT05595811
- A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid TumorsCompletedNCT05594875Phase 1
- Integrative Health Interventions in Symptom Management of Pediatric PatientsCompletedNCT05594693
- Vorasidenib Expanded Access ProgramApproved for marketingNCT05592743
- Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy SubjectsCompletedNCT05592262Phase 1
- Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)Status unknownNCT05587088Phase 1/2
- A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic CancerCompletedNCT05586516Phase 1/2
- Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid TumorsCompletedNCT05586321Phase 1
- Oral Administration of STC-15 in Subjects With Advanced MalignanciesCompletedNCT05584111Phase 1
- Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWithdrawnNCT05582031Phase 2
- A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor MalignancyTerminatedNCT05581719Phase 1/2
- Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid TumorsActive, not recruitingNCT05580991Phase 1
- A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)Active, not recruitingNCT05578976Phase 3
- Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidCompletedNCT05578820Phase 1
- Abscopal Effect From Low-dose Radiotherapy in Metastatic Cancer Combined With Stereotactic Body RadiotherapyWithdrawnNCT05578274Not applicable
- Herombopag Olamine in the Treatment of Thrombocytopenia After ChemotherapyStatus unknownNCT05575986Phase 4
- Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid MalignanciesCompletedNCT05573724Phase 1
- Effects of a Web Based Education Programme About Sexuality Aimed at Nurses That Care for Patients With CancerStatus unknownNCT05573503Not applicable
- Technology-Based Psychosocial Empowerment Program for Home Care of Children With Cancer and Their ParentsStatus unknownNCT05566951Not applicable
- Transdiagnostic Intervention to Reduce Internalized Health-Related StigmaActive, not recruitingNCT05561595Not applicable
- Study of AK119 Combined With AK104 in Patients With Advanced Solid TumorsTerminatedNCT05559541Phase 1/2
- A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United KingdomCompletedNCT05555979
- A Study of ASKG315 in Patients With Advanced Solid Tumors.Status unknownNCT05554666Phase 1
- Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian NeoplasmsCompletedNCT05553067
- The Genetic Information and Family Testing (GIFT) StudyCompletedNCT05552664Not applicable
- CRC Detection Reliable Assessment With BloodActive, not recruitingNCT05551052
- Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood CancerCompletedNCT05550948Not applicable
- Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid TumorsCompletedNCT05547906Phase 1
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid TumorsStatus unknownNCT05539157Phase 1
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsActive, not recruitingNCT05538130Phase 1
- Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid TumorsStatus unknownNCT05537987Phase 1
- Machine Learning Model to Predict HOLS and Mortality After Discharge in Hospitalized Oncologic PatientsStatus unknownNCT05534178
- Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid TumorsWithdrawnNCT05531708Phase 1
- TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)TerminatedNCT05525455Phase 1/2
- Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)TerminatedNCT05524857Phase 1
- 6MW3511 in Patients With Advanced Solid TumorStatus unknownNCT05524194Phase 1/2
- Methotrexate Combined With Immunotherapy During Radiotherapy for Solid TumorsActive, not recruitingNCT05522582Phase 2
- A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaActive, not recruitingNCT05520567Phase 1/2
- Short-term Psychodynamic Psychotherapy in Serious Physical IllnessCompletedNCT05520281Not applicable
- Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Active, not recruitingNCT05520099
- A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant TumorsCompletedNCT05516914Phase 1/2
- Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer PatientsActive, not recruitingNCT05515978Early Phase 1
- 68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational StudiesCompletedNCT05515783Phase 1/2
- Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host DiseaseWithdrawnNCT05515692Early Phase 1
- Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)CompletedNCT05514444Phase 1
- Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian OriginActive, not recruitingNCT05514028
- Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWithdrawnNCT05513612Phase 1
- Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion DetectionTerminatedNCT05513027Not applicable
- A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNCT05512390Phase 1
- A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid TumorsStatus unknownNCT05508620Phase 1
- Cancer Patient Empowerment Program: Phase 2 Feasibility StudyCompletedNCT05508412Not applicable
- A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid TumorsStatus unknownNCT05508373Phase 1
- Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid TumorsCompletedNCT05508100Phase 1
- Feasibility and Safety of Acupuncture With Semi-Permanent Needles for the Prevention of Irinotecan-Associated Diarrhea in Pediatric Solid TumorsCompletedNCT05507736Not applicable
- Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid TumorsStatus unknownNCT05505877Phase 1/2
- Pattern and Surgical Treatment of Parotid Gland NeoplasmsStatus unknownNCT05505318
- A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid TumorsTerminatedNCT05501912Phase 1
- Study of KBA1412 in Participants With Advanced Solid Malignant TumorsCompletedNCT05501821Phase 1
- Comprehensive Health Assessment for my Cancer Treatment PlanActive, not recruitingNCT05499975Not applicable
- A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid TumorsStatus unknownNCT05499715Phase 1
- Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.CompletedNCT05498051Not applicable
- Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CWCompletedNCT05497726Not applicable
- DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid TumorsTerminatedNCT05496595Phase 1
- Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"WithdrawnNCT05495802
- Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic TumorsCompletedNCT05495529
- First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid TumoursActive, not recruitingNCT05495295Phase 1
- A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT05494866Phase 1
- Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid TumorsTerminatedNCT05494762Phase 1
- Antalgic Effects of Well-being Treatments in Cancer CareCompletedNCT05493150